BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15521888)

  • 1. Hormonal treatment alone for locally advanced prostate cancer.
    Mottet N
    BJU Int; 2004 Dec; 94 Suppl 3():14-5. PubMed ID: 15521888
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine therapy for prostate cancer.
    Damber JE
    Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple intracrine hormonal targets in the prostate: opportunities and challenges.
    Labrie F
    BJU Int; 2007 Jul; 100 Suppl 2():48-51. PubMed ID: 17594360
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer drugs. Making sense of the options.
    Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer: the role of hormonal therapy.
    Salesi N; Carlini P; Ruggeri EM; Ferretti G; Bria E; Cognetti F
    J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cancer of the prostate. New hormonal approaches].
    Schaison G
    Pathol Biol (Paris); 1989 Feb; 37(2):118-9. PubMed ID: 2523530
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm.
    Guess B; Scholz M
    J Urol; 2001 May; 165(5):1644-5. PubMed ID: 11345950
    [No Abstract]   [Full Text] [Related]  

  • 10. [And what is in the works now? Recent developments in therapy of prostate cancer (interview by Constanze Loffler)].
    Miller K
    MMW Fortschr Med; 2009 Jul; 151(30-33):72-3. PubMed ID: 19722471
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.
    Kaisary AV
    Prostate Cancer Prostatic Dis; 2005; 8(2):140-51. PubMed ID: 15852051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos.
    Prescrire Int; 2007 Dec; 16(92):243. PubMed ID: 18092407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal treatment of cancer of the prostate: review and present status].
    Ganzer R; Wieland WF; Bach T; Rössler W; Blana A
    Dtsch Med Wochenschr; 2007 Jan; 132(4):161-6. PubMed ID: 17230333
    [No Abstract]   [Full Text] [Related]  

  • 14. Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art.
    Schally AV
    BJU Int; 2007 Jul; 100 Suppl 2():2-4. PubMed ID: 17594347
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
    Koutsilieris M; Dimopoulos T; Milathianakis C; Bogdanos J; Karamanolakis D; Pissimissis N; Halapas A; Lembessis P; Papaioannou A; Sourla A
    BJU Int; 2007 Jul; 100 Suppl 2():60-2. PubMed ID: 17594363
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
    Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
    Int J Urol; 2006 Jan; 13(1):87-8. PubMed ID: 16448441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total androgenic blockade: a review.
    Bianchi G; Beltrami P; Motta L; Mobilio G
    Acta Urol Belg; 1995 Sep; 63(3):11-9. PubMed ID: 7484517
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant disease of the prostate gland.
    Marsh M
    Nurs Stand; 1992 May 27-Jun 2; 6(36):28-31. PubMed ID: 1622801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up.
    Akaza H; Homma Y; Usami M; Hirao Y; Tsushima T; Okada K; Yokoyama M; Ohashi Y; Aso Y;
    BJU Int; 2006 Sep; 98(3):573-9. PubMed ID: 16925756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids and prostate cancer in castrate men.
    Plowman PN
    J Clin Oncol; 1999 Dec; 17(12):3856-60. PubMed ID: 10577863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.